Kristin Baptista

Kristin Baptista is a seasoned finance professional with extensive experience in financial planning and analysis. Currently serving as the Director of FP&A at Enanta Pharmaceuticals since July 2020, Kristin previously held the position of Associate Director of FP&A at the same organization. Prior to joining Enanta Pharmaceuticals, Kristin served as a Senior Manager at CFGI from 2007 to July 2020, a firm specializing in financial consulting. Additional experience includes managerial roles at Our Bodies Ourselves and DePuy Mitek, a Johnson & Johnson company, where Kristin held positions from Acting Financial Reporting Manager to Senior Financial Analyst. Kristin began their career as a Financial Analyst at Teradyne. Educational qualifications include an MBA from the Questrom School of Business at Boston University and a BS in Accounting from Bentley University.